These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104. Comparison of goat ATLG and ASLG in human renal transplants. Alexander JW; Smith EJ; McAdams AJ; Fidler JP; First MR; Muthiah V; Alexander NS; Korelitz J J Surg Res; 1975 Nov; 19(5):287-95. PubMed ID: 1105003 [No Abstract] [Full Text] [Related]
105. Modification of established rejection of canine kidney and liver homografts with antilymphocyte gamma-G globulin. Smith GV; Kolff J; Kashiwagi N; Putnam CW; Starzl TE Surgery; 1969 Sep; 66(3):546-9. PubMed ID: 4896070 [No Abstract] [Full Text] [Related]
106. Failure of pepsin-digested donor specific alloantibody to prolong renal allograft survival in dogs. Callender CO; Sutherland DE; Howard RJ; Toledo-Pereyra LH; Najarian JS Immunol Commun; 1974; 3(4):309-19. PubMed ID: 4618546 [No Abstract] [Full Text] [Related]
107. In vivo elimination of equine antilymphocyte globulin by renal allograft recipients. Schmidtke JR; Rynasiewicz J; Gifford RR; Ferguson RM; Najarian JS Clin Immunol Immunopathol; 1980 Mar; 15(3):409-14. PubMed ID: 6989529 [No Abstract] [Full Text] [Related]
108. T-cell count and antilymphocyte globulin therapy. Ippoliti G; Martinelli L; Negri M; Abelli P; Viganò M Transpl Int; 1994; 7(2):146. PubMed ID: 8179805 [No Abstract] [Full Text] [Related]
109. Nematospiroides dubius: mechanisms of host immunity. II. Skin testing and immunosuppression of orally or subcutaneously sensitized mice. Jones CE Exp Parasitol; 1974 Jun; 35(3):453-64. PubMed ID: 4597090 [No Abstract] [Full Text] [Related]
110. The effect of lymphocyte depletion by continuous flow centrifugation in canine renal allotransplants. Murphy GP; Williams PD; Brede HD; Mirand EA; Groenewald JH; Weber HW; Grace JT J Surg Oncol; 1970; 2(3):257-70. PubMed ID: 4939052 [No Abstract] [Full Text] [Related]
111. Lack of association of human renal allograft rejection and circulating K-cell, NK-cell, or total T-cell levels. Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lee HM; Mohanakumar T Clin Immunol Immunopathol; 1982 Dec; 25(3):335-47. PubMed ID: 6761023 [No Abstract] [Full Text] [Related]
112. The immunosuppressive activity of procarbazine hydrochloride in canine renal allografts by donor pretreatment. Varkarakis MJ; Abramczyk J; Brede HD; Murphy GP J Surg Oncol; 1972; 4(3):235-47. PubMed ID: 4560767 [No Abstract] [Full Text] [Related]
113. Clinical, biochemical, and hematologic evaluation of normal dogs after administration of rabbit anti-dog thymocyte serum. Mathews KA; Gallivan GJ; Mallard BA Vet Surg; 1993; 22(3):213-20. PubMed ID: 8362504 [TBL] [Abstract][Full Text] [Related]
114. Infectious risk factors in the immunosuppressed host. Anderson RJ; Schafer LA; Olin DB; Eickhoff TC Am J Med; 1973 Apr; 54(4):453-60. PubMed ID: 4572173 [No Abstract] [Full Text] [Related]
115. [Prolongation of the survival duration of cutaneous allograft in the rat by injections of a soluble extract from the donor's liver]. Fevrier M; Bouvet JP; Amstutz H; Liacopoulos P C R Acad Hebd Seances Acad Sci D; 1974 Oct; 279(17):1511-4. PubMed ID: 4219173 [No Abstract] [Full Text] [Related]
116. Effect of anti-thymocyte serum on development of gingivitis in dogs. Nobréus N; Attström R; Egelberg J J Periodontal Res; 1974; 9(4):227-35. PubMed ID: 4278526 [No Abstract] [Full Text] [Related]
117. A heart transplantation. 5. Postoperative medical aspects. Breslin AB; Morgan JJ; Seldon WA; Shanahan MX Med J Aust; 1969 Mar; 1(13):673-6. PubMed ID: 4890053 [No Abstract] [Full Text] [Related]